Aucta Pharmaceuticals is a technology-based company that develops and commercializes branded specialty products. By leveraging its proprietary technology platforms, Aucta develops new and innovative treatments, such as new dosage forms, dosing regimens and indications, for specific indications, and improves the performance of existing products. It has a distinct therapeutic focus in CNS, dermatology and pediatrics. These products will be submitted to the FDA via the 505(b)(2) regulatory pathway. Aucta has offices in New Jersey, US, and Shanghai, China.